Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2300060	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2023-04-05		Novo Nordisk A/S			view
JXSL1200060	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Import Drug Application	2012-09-06		Bayer Healthcare AG	Certificate Issued	2013-10-29	view
JYSZ2400009	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2024-01-13					view
JYSB2101206	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
JTS2400067	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Disposable Import Drug Application	2024-08-08					view
JXSL1200059	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Import Drug Application	2012-09-06		Bayer Healthcare AG	Certificate Issued	2013-10-29	view
CXSS2300097	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products(3.4)	New Drug Application	2023-12-14		Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group			view
JYSZ2400007	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2024-01-13					view
JYSB2300059	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2023-04-05		Novo Nordisk A/S			view
JYSB2101207	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
JYSZ2400008	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2024-01-13					view
JYSB2300061	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2023-04-05		Novo Nordisk A/S			view
JYSB2101208	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
JYSB2000125	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2020-04-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-11-24	view
JYSB1400004	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2014-01-10	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2015-12-17	view
J0401235	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2004-12-02	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2005-03-03	view
JYSB1700198	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2017-11-14	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2017-12-04	view
JYSB0800151	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2008-12-05	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2010-06-03	view
JYSZ1900037	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2019-07-05	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-03-02	view
JYSB1600066	注射用重组人凝血因子VIIa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2016-04-20	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2016-07-18	view